Showing results (11-20 of 22) with videos related to
Sort By:
Pageof 3
Journal of Nutrition Education and Behavior|October 21, 2018
Double Up Food Bucks Participation is Associated with Increased Fruit and Vegetable Consumption and Food Security Among Low-Income AdultsCarrie M Durward, Mateja Savoie-Roskos, Abiodun Atoloye, et al.Nature Medicine|March 5, 2002
Tumor-cell resistance to death receptor--induced apoptosis through mutational inactivation of the proapoptotic Bcl-2 homolog BaxHeidi LeBlanc, David Lawrence, Eugene Varfolomeev, et al.Nutrients|August 14, 2025
Evaluation of Diet Quality, Physical Health, and Mental Health Baseline Data from a Wellness Intervention for Individuals Living in Transitional HousingCallie Millward, Kyle Lyman, Soonwye Lucero, et al.Journal of Nutrition Education and Behavior|February 4, 2025
Formative Qualitative Research Informs Tailoring SNAP-Ed Curriculum for Transitional Housing ResidentsKristi Strongo, Casey Coombs, James D LeCheminant, et al.Cell|December 6, 2005
TWEAK attenuates the transition from innate to adaptive immunityHeather Maecker, Eugene Varfolomeev, Frank Kischkel, et al.Journal for Immunotherapy of Cancer|August 14, 2024
Case report of fatal immune-mediated myocarditis following treatment with davoceticept (ALPN-202), a PD-L1-dependent CD28 costimulator and dual PD-L1/CTLA-4 checkpoint inhibitor, in combination with pembrolizumabLudimila Cavalcante, Sreenivasa Chandana, Nehal Lakhani, et al.Arthritis and Rheumatism|December 8, 2011
A phase II, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of MDX-1100, a fully human anti-CXCL10 monoclonal antibody, in combination with methotrexate in patients with rheumatoid arthritisMichael Yellin, Igor Paliienko, Andra Balanescu, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 20, 2018
A Novel, Fully Human Anti-fucosyl-GM1 Antibody Demonstrates Potent <i>In Vitro</i> and <i>In Vivo</i> Antitumor Activity in Preclinical Models of Small Cell Lung CancerPaul Ponath, Daniel Menezes, Chin Pan, et al.Cancer Immunology Research|May 30, 2014
In vitro characterization of the anti-PD-1 antibody nivolumab, BMS-936558, and in vivo toxicology in non-human primatesChangyu Wang, Kent B Thudium, Minhua Han, et al.Journal for Immunotherapy of Cancer|August 3, 2024
Phase I studies of davoceticept (ALPN-202), a PD-L1-dependent CD28 co-stimulator and dual PD-L1/CTLA-4 inhibitor, as monotherapy and in combination with pembrolizumab in advanced solid tumors (NEON-1 and NEON-2)Diwakar Davar, Ludimila Cavalcante, Nehal Lakhani, et al.Pageof 3